NCM
ABBV icon

Next Capital Management’s AbbVie ABBV Stock Holding History

Next Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-889
Closed -$203K – 135
2025
Q4 		$203K Sell
889
-675
-43% -$154K 0.07% 124
2025
Q3 		$362K Sell
1,564
-313
-17% -$63.7K 0.12% 93
2025
Q2 		$348K Buy
1,877
+307
+20% +$57.1K 0.13% 96
2025
Q1 		$329K Sell
1,570
-879
-36% -$171K 0.16% 89
2024
Q4 		$435K Buy
2,449
+333
+16% +$61.2K 0.18% 91
2024
Q3 		$418K Sell
2,116
-185
-8% -$34.5K 0.17% 93
2024
Q2 		$395K Sell
2,301
-70
-3% -$11.6K 0.17% 95
2024
Q1 		$432K Buy
2,371
+380
+19% +$65.5K 0.17% 91
2023
Q4 		$309K Buy
1,991
+241
+14% +$35.1K 0.13% 96
2023
Q3 		$261K Buy
+1,750
New +$257K 0.12% 97
2023
Q2 		– Sell
-1,315
Closed -$210K – 118
2023
Q1 		$210K Hold
1,315
– – 0.1% 111
2022
Q4 		$213K Sell
1,315
-378
-22% -$58K 0.11% 107
2022
Q3 		$227K Buy
1,693
+186
+12% +$26.7K 0.17% 93
2022
Q2 		$230K Buy
1,507
+7
+0.5% +$1.07K 0.17% 96
2022
Q1 		$243K Hold
1,500
– – 0.16% 100
2021
Q4 		$203K Buy
+1,500
New +$177K 0.14% 101
2021
Q2 		– Sell
-1,892
Closed -$205K – 109
2021
Q1 		$205K Sell
1,892
-278
-13% -$29.7K 0.13% 107
2020
Q4 		$233K Buy
+2,170
New +$209K 0.16% 95
2019
Q3 		– Sell
-299
Closed -$22K – 255
2019
Q2 		$22K Buy
+299
New +$23.5K 0.01% 267
2019
Q1 		– Sell
-21
Closed -$2K – 252
2018
Q4 		$2K Buy
+21
New +$1.85K ﹤0.01% 219

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Next Capital Management's ABBV Position: Q1 2026 in Review

Next Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 889 shares — an estimated $203K sold.

Next Capital Management first reported a position in ABBV in Q4 2018 and held it in 20 quarters. The position peaked at $435K in Q4 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Next Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Next Capital Management sold 889 AbbVie shares in Q1 2026, an estimated $203K.
  • Next Capital Management first reported a position in AbbVie in Q4 2018 and held it in 20 quarters.
  • Next Capital Management's AbbVie position peaked at $435K in Q4 2024.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Next Capital Management's 13F filing for Q1 2026, filed 7 May 2026.